glp 1 drugs for weight loss Patients' Use GLP-1 Loss, Benefit Gains Popular GLP-1 medications may have

Liu trnh 4 hp (dng 3 thng) c hiu qu ti u

Abbreviations CKD: Chronic kidney disease DKA: Diabetic ketoacidosis FDA: US Food and Drug Administration GLP-1 RA: Glucagon-like peptide-1 receptor agonist HCO: Healthcare organisation IHD: Ischaemic heart disease PSM: Propensity score matching SGLT2i: Sodium-glucose cotransporter 2 inhibitor SSMD: Strictly standardised mean difference UTI: Urinary tract infection References Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study

Myrosinase catalyzes the hydrolysis of endogenous glucosinolates into biologically active goitrogenic compounds, including thiocyanates and nitriles, potentially resulting in goiter and hypothyroidism

Tesamorelin Side Effects Like any peptide therapy, tesamorelin may cause side effects in some individuals